全球智库信息集成服务系统(G2TT): Frameworks for pharmaceutical innovation in developing countries

G2TT

来源类型	Article
规范类型	其他
DOI	10.1080/09537320701521465
ISBN	0953-7325
	Frameworks for pharmaceutical innovation in developing countries - the case of Indian pharma.
	Chataway, Joanna; Tait, Joyce; Wield, David
发表日期	2007-09-06
出处	Technology Analysis and Strategic Management
出版者	Taylor & Francis
出版年	2007
页码	697-708
语种	英语
摘要	Some industrially advanced developing countries have, in the last decades, built substantial pharmaceutical scientific and industrial capabilities. The more advanced of these countries have built chemical and biological R&D, generic and reverse engineering, and drug discovery capabilities. There have been tremendous barriers to entry but nevertheless a range of imitative approaches have evolved, with some significant scientific, health and industrial advances. Opportunities in India are in part created by the problems of maturity being faced by big pharmaceutical firms in developed countries. Big pharmaceutical firms are searching for novel approaches to retain a high value-added model of innovation for drug development. These difficulties provide opportunities for innovative companies in developing countries. This paper explores the challenges faced under these circumstances by Indian pharmaceutical companies. Are they attempting to 'catch-up' by chasing a failing model of innovation? Do they have an alternative model? Or can they become an important part of a transformed new global model of pharmaceutical innovation?
关键词	Developing world, Drug development, Innovation, Pharmaceutical industry, Research and development, Asia, Eurasia, India, South Asia
URL	http://sro.sussex.ac.uk/id/eprint/65286/
来源智库	Science Policy Research Unit (United Kingdom)
引用统计
资源类型	智库出版物
条目标识符	http://119.78.100.153/handle/2XGU8XDN/467375
推荐引用方式 GB/T 7714	Chataway, Joanna,Tait, Joyce,Wield, David. Frameworks for pharmaceutical innovation in developing countries - the case of Indian pharma.. 2007.